Department of Surgery, Section of Vascular and Endovascular Surgery, St Joseph Mercy Health System, Ann Arbor, MI, USA.
Methods Consultants, Ypsilanti, MI, USA.
Vascular. 2024 Feb;32(1):57-64. doi: 10.1177/17085381221104630. Epub 2022 Aug 4.
Intravascular ultrasound (IVUS) is a uniquely objective but underutilized imaging modality in the interventional treatment of peripheral arterial disease treatment. IVUS has been shown to improve device size selection and diagnose occult pathology difficult to see with routine angiography. We hypothesize that the use of IVUS in lower extremity endovascular intervention improves accuracy in stent and balloon size selection and minimizes contrast use.
This is a retrospective case series performed at a single-institution outpatient center by two vascular surgeons from July 2016 through July 2017. We identified 94 total IVUS-assisted procedures. We collected data regarding demographics, balloon and stent size, IVUS-determined vessel diameter, pre-procedure and post-procedure ABI values, and contrast used during the procedure. An independent core laboratory was further utilized to characterize all IVUS and angiographic size vessel measurements.
For the 94 lower extremity IVUS-assisted interventions, the average patient age was 70±9 years old, with an average contrast use of 37.1 mL of Omnipaque 300. There was substantial improvement in pre- and post-procedure ABI (0.7±0.23 to 0.94±0.21). On analysis of average intraluminal IVUS vessel diameter to balloon angioplasty used, we had a correlation in size of 0.96±0.16 in our series. Additionally, in eight instances IVUS allowed for identification of a flow-limiting dissection with subsequent stenting.
Routine use of IVUS offers a powerful diagnostic paradigm that has the potential to significantly decrease contrast use and to improve objectivity in choosing appropriate vascular tools to maximize intra-procedural efficacy. The discovery of adverse findings not initially noticed on angiography further reinforces the value of IVUS utilization.
血管内超声(IVUS)是一种独特的客观成像方式,但在周围动脉疾病治疗的介入治疗中应用不足。IVUS 已被证明可以改善器械尺寸选择,并诊断常规血管造影难以发现的隐匿性病变。我们假设在下肢血管腔内介入治疗中使用 IVUS 可以提高支架和球囊尺寸选择的准确性,并最大限度地减少造影剂的使用。
这是一项单中心回顾性病例系列研究,由两名血管外科医生于 2016 年 7 月至 2017 年 7 月在门诊进行。我们共确定了 94 例 IVUS 辅助手术。我们收集了患者的人口统计学数据、球囊和支架的尺寸、IVUS 确定的血管直径、术前和术后踝肱指数(ABI)值,以及手术过程中使用的造影剂。还进一步使用独立的核心实验室对所有 IVUS 和血管造影的血管尺寸测量值进行特征描述。
在 94 例下肢 IVUS 辅助介入治疗中,患者平均年龄为 70±9 岁,平均使用 37.1ml 的欧乃派克 300 造影剂。ABI(踝肱指数)从术前的 0.7±0.23 显著改善至术后的 0.94±0.21。对平均腔内 IVUS 血管直径与球囊血管成形术使用的分析显示,我们的系列研究中两者之间存在 0.96±0.16 的相关性。此外,在 8 例中,IVUS 发现了一处导致血流受限的夹层,随后进行了支架置入。
常规使用 IVUS 提供了一种强大的诊断模式,有可能显著减少造影剂的使用,并提高选择合适血管工具的客观性,以最大限度地提高术中疗效。在血管造影术最初未发现的不良发现的发现进一步强化了 IVUS 应用的价值。